ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 668 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $57,220,000 | +20.7% | 734,019 | +4.8% | 0.09% | +14.3% |
Q1 2024 | $47,423,000 | +4.7% | 700,386 | +4.0% | 0.08% | +1.3% |
Q4 2023 | $45,307,000 | +2.3% | 673,283 | +3.0% | 0.08% | -8.4% |
Q3 2023 | $44,283,000 | +124.4% | 653,843 | +137.6% | 0.08% | +112.8% |
Q2 2023 | $19,733,000 | +25.6% | 275,242 | +21.6% | 0.04% | +14.7% |
Q1 2023 | $15,715,000 | +12.0% | 226,424 | +9.4% | 0.03% | +6.2% |
Q4 2022 | $14,035,000 | +18.4% | 207,002 | -4.1% | 0.03% | 0.0% |
Q3 2022 | $11,851,000 | -5.3% | 215,884 | +14.1% | 0.03% | 0.0% |
Q2 2022 | $12,511,000 | +35.3% | 189,284 | +35.8% | 0.03% | +52.4% |
Q1 2022 | $9,248,000 | -21.7% | 139,358 | -31.3% | 0.02% | -19.2% |
Q4 2021 | $11,811,000 | -0.1% | 202,748 | +3.1% | 0.03% | -18.8% |
Q3 2021 | $11,818,000 | +23.3% | 196,666 | +23.1% | 0.03% | +14.3% |
Q2 2021 | $9,584,000 | +59.4% | 159,820 | +30.8% | 0.03% | +47.4% |
Q1 2021 | $6,012,000 | +16.7% | 122,179 | +17.5% | 0.02% | -9.5% |
Q4 2020 | $5,150,000 | +21.0% | 103,962 | +33.6% | 0.02% | 0.0% |
Q3 2020 | $4,255,000 | +57.4% | 77,831 | +52.3% | 0.02% | +40.0% |
Q2 2020 | $2,703,000 | +15.5% | 51,098 | -2.6% | 0.02% | 0.0% |
Q1 2020 | $2,340,000 | -7.2% | 52,439 | -7.5% | 0.02% | +7.1% |
Q3 2019 | $2,522,000 | +24.3% | 56,678 | +15.0% | 0.01% | +16.7% |
Q2 2019 | $2,029,000 | -4.6% | 49,276 | -6.8% | 0.01% | -14.3% |
Q1 2019 | $2,126,000 | -3.0% | 52,850 | -8.2% | 0.01% | -17.6% |
Q4 2018 | $2,191,000 | -6.6% | 57,601 | -2.5% | 0.02% | 0.0% |
Q3 2018 | $2,345,000 | -43.4% | 59,093 | -49.8% | 0.02% | -46.9% |
Q2 2018 | $4,141,000 | -4.3% | 117,764 | -5.0% | 0.03% | -11.1% |
Q1 2018 | $4,326,000 | -5.3% | 123,976 | -6.0% | 0.04% | -5.3% |
Q4 2017 | $4,569,000 | -7.8% | 131,918 | -9.9% | 0.04% | -9.5% |
Q3 2017 | $4,955,000 | +6.8% | 146,354 | +7.3% | 0.04% | 0.0% |
Q2 2017 | $4,640,000 | -20.4% | 136,427 | -27.2% | 0.04% | -25.0% |
Q1 2017 | $5,826,000 | +8.9% | 187,469 | -4.3% | 0.06% | -3.4% |
Q4 2016 | $5,348,000 | -46.0% | 195,923 | -35.0% | 0.06% | -49.6% |
Q3 2016 | $9,907,000 | +1.5% | 301,468 | -6.7% | 0.12% | -7.3% |
Q2 2016 | $9,764,000 | -37.1% | 323,247 | -41.4% | 0.12% | +143.1% |
Q1 2016 | $15,531,000 | -13.4% | 551,304 | +4.4% | 0.05% | -76.1% |
Q4 2015 | $17,939,000 | -28.4% | 528,302 | -32.9% | 0.21% | -35.8% |
Q3 2015 | $25,056,000 | +14.0% | 786,937 | +145.0% | 0.33% | +1.5% |
Q1 2015 | $21,978,000 | +14.6% | 321,172 | +17.9% | 0.33% | +11.2% |
Q4 2014 | $19,184,000 | +89.6% | 272,318 | +92.3% | 0.29% | +71.9% |
Q3 2014 | $10,116,000 | -18.5% | 141,597 | -15.3% | 0.17% | -20.5% |
Q2 2014 | $12,418,000 | +1498.2% | 167,111 | +1295.1% | 0.22% | +1333.3% |
Q1 2014 | $777,000 | -13.3% | 11,978 | -20.7% | 0.02% | -16.7% |
Q4 2013 | $896,000 | -83.2% | 15,096 | -85.2% | 0.02% | -86.5% |
Q3 2013 | $5,319,000 | +20.2% | 102,145 | +9.2% | 0.13% | +10.8% |
Q2 2013 | $4,425,000 | – | 93,556 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |